Patents Assigned to NEUVIVO, INC.
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 12109231
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: February 14, 2024
    Date of Patent: October 8, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 12109229
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: February 14, 2024
    Date of Patent: October 8, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 12109228
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: February 14, 2024
    Date of Patent: October 8, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 12109230
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: February 14, 2024
    Date of Patent: October 8, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 11938148
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: March 26, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 11938150
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: March 26, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 11938149
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: March 26, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath
  • Treatment of neurodegenerative disease with sodium chlorite
    Patent number: 11938147
    Abstract: The present invention provides a method of treating frontotemporal dementia, or a childhood genetic neurodegenerative disease such as Ataxia Telangiectasia (A-T), or neurodegenerative diseases such as Parkinson's disease or neuropsychiatric diseases comprising administering to a subject in need thereof an effective amount of chlorite composition, such as sodium chlorite. The present invention thereby provides a method of modulating the immune system in a subject in need thereof. Described herein are methods of administration and treatment.
    Type: Grant
    Filed: August 30, 2022
    Date of Patent: March 26, 2024
    Assignees: NEUVIVO, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Vernon A. Norviel, Michael S. McGrath